Skip to main content
. 2024 Feb;30(2):310–320. doi: 10.3201/eid3002.230122

Figure 7.

Figure 7

Zika virus neutralizing antibody titers from acute and convalescent serum samples supporting reinfection among 5 study participants in northern Brazil. A) Participant ID151006; B) participant ID151026; C) participant ID151035; D) participant ID251064; E) participant ID251069. Dotted lines and red numbers represent fold changes in titers as calculated from the 180-day and 360-day intervals. MN50, 50% percent microneutralization assay.